 |
PDBsum entry 5g0b
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lyase
|
 |
|
Title:
|
 |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c
|
|
Structure:
|
 |
Carbonic anhydrase 2. Chain: a. Fragment: catalytic domain, unp residues 1-260. Synonym: carbonate dehydratase ii, carbonic anhydrasE C, cac, carbonic anhydrase ii, ca-ii. Engineered: yes. Mutation: yes. Other_details: caii backbone with catalytic site mutations to make it look like caxii
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 511693.
|
|
Resolution:
|
 |
|
1.55Å
|
R-factor:
|
0.135
|
R-free:
|
0.179
|
|
|
Authors:
|
 |
P.Mujumdar,C.T.Supuran,T.S.Peat,S.A.Poulsen
|
|
Key ref:
|
 |
P.Mujumdar
et al.
(2016).
An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C.
J Med Chem,
59,
5462-5470.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Mar-16
|
Release date:
|
25-May-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00918
(CAH2_HUMAN) -
Carbonic anhydrase 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
260 a.a.
257 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 10 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.4.2.1.1
- carbonic anhydrase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
hydrogencarbonate + H+ = CO2 + H2O
|
 |
 |
 |
 |
 |
hydrogencarbonate
|
+
|
H(+)
|
=
|
CO2
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.4.2.1.69
- cyanamide hydratase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
urea = cyanamide + H2O
|
 |
 |
 |
 |
 |
urea
|
=
|
cyanamide
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
59:5462-5470
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C.
|
|
P.Mujumdar,
K.Teruya,
K.F.Tonissen,
D.Vullo,
C.T.Supuran,
T.S.Peat,
S.A.Poulsen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Psammaplin C is one of only two described natural product primary sulfonamides.
Here we report the synthesis of psammaplin C and evaluate the inhibition profile
against therapeutically relevant carbonic anhydrase (CA) zinc metalloenzymes.
The compound exhibited unprecedented inhibition of an important
cancer-associated isozyme, hCA XII, with a Ki of 0.79 nM. The compound also
displayed good isoform selectivity for hCA XII over other CAs. We present the
first reported protein X-ray crystal structures of psammaplin C in complex with
human CAs. We engineered the easily crystallized hCA II enzyme to mimic both the
hCA IX and hCA XII binding sites and then utilized protein X-ray crystallography
to determine the binding pose of psammaplin C within the hCA II, hCA IX, and hCA
XII mimic active sites, all to high resolution. This is the first time a natural
product primary sulfonamide inhibitor has been assessed for inhibition and
binding to CAs.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |